| Literature DB >> 33484329 |
Ying Luo1, Tianwei Jia1, Jieqiong Fang1, Dandan Liu1, Varma Saikam1, Xiaolin Sheng1, Suri S Iyer2.
Abstract
Strict adherence to highly active antiretroviral therapy (HAART) is very important to improve the quality of life for HIV-positive patients to reduce new infections and determine treatment success. Azidothymidine (AZT) is an antiretroviral drug commonly used in HAART treatment. In this research, an "add, mix, and measure" assay was developed to detect AZT within minutes. Three different probes designed to release fluorophores when samples containing AZT are added were synthesized and characterized. The limit of detection to AZT in simulated urine samples was determined to be 4 μM in 5 min for one of the probes. This simple and rapid point-of-care test could potentially be used by clinicians and health care workers to monitor the presence of AZT in low resource settings.Entities:
Keywords: Azidothymidine; Fluorescence; HIV; Point-of-care; Therapeutic drug monitoring
Mesh:
Substances:
Year: 2021 PMID: 33484329 PMCID: PMC8276851 DOI: 10.1007/s00216-021-03168-z
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142